Actively Recruiting
An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms
Led by Qbtech AB · Updated on 2026-05-06
300
Participants Needed
1
Research Sites
43 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate QbMobile's ability to collect objective data to identify specific symptom profiles in differential diagnoses (ASD, MDD, Bipolar Disorder and Anxiety Disorder) that are common with ADHD.
CONDITIONS
Official Title
An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Provide written informed consent (including parental or guardian consent and assent if under 18) for QbMobile
- Aged over 6 years and under 60 years old
- Referred for initial assessment or previously diagnosed with ASD, MDD, Bipolar Disorder, or Anxiety Disorder but not currently receiving treatment
- Meets DSM-5 or ICD-11 criteria for primary diagnosis of ASD, MDD, Bipolar Disorder, or Anxiety Disorder according to clinical procedures
- Have adequate sensory and physical ability to complete QbMobile
- Possess or have access to an iPhone that supports QbMobile
You will not qualify if you...
- Intellectual disability with IQ less than 70
- Diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, psychotic disorder due to another medical condition, PTSD, antisocial personality disorder, or borderline personality disorder
- Primary diagnosis of ADHD (any presentation)
- Medical conditions affecting test performance such as brain injuries, Parkinson's disease, epilepsy or active seizures, ALS, multiple sclerosis, dementias
- Conditions affecting test performance like severe migraine or chronic/acute pain
- Use of prescription medications (e.g., anxiolytics, sedatives) the day before testing that could affect performance
- Substance use (alcohol, drugs) that may affect performance on testing days
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CCM Clinical Research Group
Miami, Florida, United States, 33133
Actively Recruiting
Research Team
R
Robert Nolen
CONTACT
R
Ragini Sanyal
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
6
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here